A

Antiva Biosciences, Inc. / previously know as Hera Therapeutics

17 employees

Antiva Biosciences is a biopharmaceutical company developing therapeutics for the treatment of diseases caused by HPV infection.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Health Care

Medical

Date founded

2012

Funding rounds raised

Total raised

$53M

from 28 investors over 28 rounds

A

Antiva Biosciences, Inc. / previously know as Hera Therapeutics raised $53M on April 27, 2023

Investors: GV, Canaan, Lumira Ventures, Adjuvant Capital, Sofinnova Ventures, Russia technology fund and BioImpact Capital

A

Antiva Biosciences, Inc. / previously know as Hera Therapeutics raised $31M on November 2, 2021

Investors: Mana Ventures, Canaan, Lumira Ventures, Osage University Partners (OUP), Sofinnova Ventures, Russia technology fund, GV and Sirona Capital

A

Antiva Biosciences, Inc. / previously know as Hera Therapeutics raised $15M on July 10, 2018

Investors: NS Investment, JLABS, Canaan, Sirona Capital, Osage University Partners (OUP), Brace Pharma Capital, Hillhouse Capital Management and Sofinnova Ventures, Russia technology fund

A

Antiva Biosciences, Inc. / previously know as Hera Therapeutics raised $22M on March 28, 2017

Investors: NS Investment, Brace Pharma Capital, Sofinnova Ventures, Russia technology fund, Canaan and Osage University Partners (OUP)

A

Antiva Biosciences, Inc. / previously know as Hera Therapeutics raised $16M on August 6, 2015

Investors: Canaan and Sofinnova Ventures, Russia technology fund